XSHE
300239
Market cap490mUSD
Oct 09, Last price
5.54CNY
1D
0.18%
1Q
5.32%
Jan 2017
-31.44%
IPO
18.99%
Name
Baotou Dongbao Bio-Tech Co Ltd
Chart & performance
P/E
60.52
P/S
4.41
EPS
0.09
Div yield, %
0.45%
Shrs. gr., 5y
2.10%
Rev. gr., 5y
4.01%
Revenues
745m
-15.78%
Net income
54m
-36.80%
CFO
106m
+53.22%
Dividend
May 27, 20260.012 CNY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Baotou Dongbao Bio-Tech Co., Ltd. specializes in the research, manufacturing, and global sales of gelatin and collagen products, serving both domestic and international markets. Their offerings include gelatin for food additives and pharmaceutical applications, as well as collagen peptides. The company was founded in 1997 and is headquartered in Baotou, People's Republic of China.
Key people
Chairman of the Board · since 2021
Haiqing Hao
Chief Financial Officer · since 2019
Fang Liu
General Manager, Director · since 2024
Jianguang Du
Deputy General Manager · since 2024
Huayi Shan
Deputy General Manager, Secretary of the Board · since 2024
Furong Wang
Deputy General Manager, Director · since 2016
Yan Liu
Deputy General Manager, Director · since 2021
Bin Ren
Independent Director · since 2020
E'erduntaoketao Tao
Independent Director · since 2024
Jing Wang
Independent Director · since 2024
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2023‑00 | 2022‑12 | 2022‑00 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||||
Revenues | ||||||||||||
Cost of revenue | ||||||||||||
Unusual Expense (Income) | ||||||||||||
NOPBT | ||||||||||||
NOPBT Margin | ||||||||||||
Operating Taxes | ||||||||||||
Tax Rate | ||||||||||||
NOPAT | ||||||||||||
Net income | ||||||||||||
Dividends | ||||||||||||
Dividend yield | ||||||||||||
Proceeds from repurchase of equity | ||||||||||||
BB yield | ||||||||||||
| Debt | ||||||||||||
Debt current | ||||||||||||
Long-term debt | ||||||||||||
Deferred revenue | ||||||||||||
Other long-term liabilities | ||||||||||||
Net debt | ||||||||||||
| Cash flow | ||||||||||||
Cash from operating activities | ||||||||||||
CAPEX | ||||||||||||
Cash from investing activities | ||||||||||||
Cash from financing activities | ||||||||||||
FCF | ||||||||||||
| Balance | ||||||||||||
Cash | ||||||||||||
Long term investments | ||||||||||||
Excess cash | ||||||||||||
Stockholders' equity | ||||||||||||
Invested Capital | ||||||||||||
ROIC | ||||||||||||
ROCE | ||||||||||||
| EV | ||||||||||||
Common stock shares outstanding | ||||||||||||
Price | ||||||||||||
Market cap | ||||||||||||
EV | ||||||||||||
EBITDA | ||||||||||||
EV/EBITDA | ||||||||||||
Interest | ||||||||||||
Interest/NOPBT | ||||||||||||